Skip to content

Combined Treatment With Pulsed Light and Photobiomodulation Before Laser Refractive Surgery

Combined Treatment With Pulsed Light and Photobiomodulation Before Laser Refractive Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05803798
Acronym
TEBELID
Enrollment
62
Registered
2023-04-07
Start date
2023-06-06
Completion date
2025-04-16
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye, Dry Eye After LASIK-Laser in Situ Keratomileusis

Keywords

dry eye, laser refractive surgery, smile, lasik, presbylasik, photorefractive keratectomy, intense-pulsed light, low-level-light therapy, photobiomodulation

Brief summary

Laser corneal refractive surgery is a widely adopted approach for correcting refractive errors, but postoperative dry eye remains a common side effect. Intense Pulsed Light (IPL) and Low-Level Light Therapy (LLLT) are two emerging treatments that have shown potential in managing dry eye disease. However, their role as a prophylactic treatment in patients without pre-existing symptomatic dry eye undergoing refractive surgery has not been explored.

Detailed description

monocentric, randomized, simple bling, controlled study

Interventions

DEVICEIPL+LLLT

preventive treatment by IPL+LLLT (EYE-LIGHT) before laser refractive surgery

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Investigator)

Intervention model description

Treatment group = LLLT+IPL (EYE-LIGHT) before laser refractive surgery

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Patients eligible for laser corneal refractive surgery (FS-LASIK, SMILE®, or PRK) who meet the inclusion criteria will be enrolled.

Exclusion criteria

include age \< 18 and contraindications to IPL or LLLT (e.g., pregnancy, lactation, migraine, epilepsy, palpebral or periocular lesion, photosensitive drugs, cardiac pacing system or implantable cardiovertor defibrillator, Fitzpatrick phototypes V and VI).

Design outcomes

Primary

MeasureTime frameDescription
French version of Ocular Surface Disease Index (OSDI) score1 month post-operativeThe OSDI questionnaire measures frequency of symptoms, environmental triggers and vision related quality of life. OSDI values range from 0 to 100. A score between 13 and 22 excluded indicates a medium intensity eye dryness. A score between 22 and 33 indicated a moderate intensity eye dryness. A score above 33 indicates a severe eye dryness.

Secondary

MeasureTime frameDescription
Evolution of Schirmer I test over the 6 first months post-operative6 months post-operativeThe Schirmer I test, used without anesthesia, provides an estimation of stimulated reflex. Cut-off value used is \<= 10 mm / 5 minutes.
Evolution of Meibomian Gland Dropout over the 6 first months post-operative6 months post-operativeMeibomian Gland Dropout: Evaluated via infrared images using LipiView™ II (Quantel Medical) and graded using the Gestalt Grading Scale (GGS), which scores meibomian gland loss on a scale from 1 (no loss) to 4 (\>75% loss).
Evolution of Fluorescein Break-up Time (FBUT) over the 6 first months post-operative6 months post-operativeSodium fluorescein eye drops is instilled in the eye to enhance visibility of the tear film measure tear film breakup time is. Selected cut-off value is 10 seconds. A score below 10 seconds favors dry eye.
Evolution of visual acuity over the 6 first months post-operative6 months post-operativeVisual acuity measured preoperatively (corrected) and postoperatively (uncorrected) using the Early Treatment of Diabetic Retinopathy Study (ETDRS) scale at 4 meters. Visual acuity is scored by adding 30 to the total number of letters read correctly at 4 meters
Evolution of the French version of Ocular Surface Disease Index (OSDI) score over the 6 first months post-operative6 months post-operativeThe OSDI questionnaire measures frequency of symptoms, environmental triggers and vision related quality of life. OSDI values range from 0 to 100. A score between 13 and 22 excluded indicates a medium intensity eye dryness. A score between 22 and 33 indicated a moderate intensity eye dryness. A score above 33 indicates a severe eye dryness.
Evolution of the Oxford score over the 6 first months post-operative6 months post-operativeThe Oxford score is composed of 0 to V grades, dependent on intensity of punctate staining displayed. pictorially across a combination of the cornea and conjunctiva.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026